Enterprise Investors invests in PharmaSwiss

Polish Enterprise Fund VI, a private equity fund managed by Enterprise Investors, will acquire 12.7% of PharmaSwiss in a capital increase transaction for € 35 million. PharmaSwiss is the largest third party pharmaceutical sales and marketing outsourcing company in the Central and Eastern European region.

PharmaSwiss SA (www.pharmaswiss.com)
Established in 2000 and based in Zug, Switzerland, PharmaSwiss offers full third party representation of specified drugs or portfolios from research-based pharmaceutical and biotech companies, including drug registration, promotion, sales, compliance and pharma-covigilance. The Company represents several blue chip clients such as Bristol-Mysers Squibb, Wyeth Pharmaceuticals, Beaufour Ipsen, Astellas Pharma, Eli Lilly and Ferring.

PharmaSwiss currently operates in numerous countries in Southeast and Central Europe as well as Israel. In 2008, PharmaSwiss will launch operations in new countries: Hungary, Romania and Poland. Development plans for the following years include also entering Russia and Turkey.

The Company had revenues of more than € 100 million and nearly 500 employees in 2007.

Polish Enterprise Fund VI (PEF VI) will become an owner of PharmaSwiss alongside its two founders and the specialized healthcare investor HBM BioVentures, which invested in the Company in 2007.

Enterprise Investors (www.ei.com.pl)
Enterprise Investors is one of the oldest and largest private equity firms in Central and Eastern Europe. Active since 1990, the company manages funds with capital exceeding € 1.6 billion. These funds have invested € 1 billion in 107 companies in Poland and other Central and Eastern European countries, and exited 91 investments with total proceeds of over € 1.3 billion.

Enterprise Investors has broad experience in investing in the pharmaceutical and healthcare market in the CEE region, having been a major investor in such Polish companies as Polfa Kutno (pharmaceuticals producer), Polska Grupa Farmaceutyczna (pharma distributor), Pharmag, Apteka 21 (chain of pharmacies) and Medycyna Rodzinna (chain of primary care clinics).